ベーチェット病治療の世界市場（～2026年）

• 英文タイトル：Global Behcet Disease Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11034
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はベーチェット病治療のグローバル市場について調査・分析したレポートです。種類別（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他）市場規模、用途別（在宅介護、病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ベーチェット病治療の競争状況、市場シェア
・世界のベーチェット病治療市場：種類別市場規模 2015年-2020年（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他）
・世界のベーチェット病治療市場：種類別市場規模予測 2021年-2026年（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他）
・世界のベーチェット病治療市場：用途別市場規模 2015年-2020年（在宅介護、病院、クリニック）
・世界のベーチェット病治療市場：用途別市場規模予測 2021年-2026年（在宅介護、病院、クリニック）
・北米のベーチェット病治療市場分析：米国、カナダ
・ヨーロッパのベーチェット病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのベーチェット病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のベーチェット病治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのベーチェット病治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：AbbVie Inc、Celgene Corp、Coherus BioSciences Inc、Novartis AG、R Pharm、Cell Medica Ltd、Panacea Biotec Ltd
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Behcet disease, also called Behcet’s syndrome, is a rare disorder that causes blood vessel inflammation throughout your body.

Market Analysis and Insights: Global Behcet Disease Treatment Market
The global Behcet Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Behcet Disease Treatment Scope and Market Size
Behcet Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Behcet Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AbbVie Inc
Celgene Corp
Coherus BioSciences Inc
Novartis AG
R Pharm
Cell Medica Ltd
Panacea Biotec Ltd
…

Market segment by Type, the product can be split into
Adalimumab Biosimilar
Apremilast
Canakinumab
Infliximab Biosimilar
Others
Market segment by Application, split into
Home Care
Hospital
Clinic

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Behcet Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Behcet Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Adalimumab Biosimilar
1.4.3 Apremilast
1.4.4 Canakinumab
1.4.5 Infliximab Biosimilar
1.4.6 Others
1.5 Market by Application
1.5.1 Global Behcet Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Home Care
1.5.3 Hospital
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Behcet Disease Treatment Market Perspective (2015-2026)
2.2 Global Behcet Disease Treatment Growth Trends by Regions
2.2.1 Behcet Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Behcet Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Behcet Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Behcet Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Behcet Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Behcet Disease Treatment Players by Market Size
3.1.1 Global Top Behcet Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Behcet Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Behcet Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Behcet Disease Treatment Market Concentration Ratio
3.2.1 Global Behcet Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Behcet Disease Treatment Revenue in 2019
3.3 Behcet Disease Treatment Key Players Head office and Area Served
3.4 Key Players Behcet Disease Treatment Product Solution and Service
3.5 Date of Enter into Behcet Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Behcet Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Behcet Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Behcet Disease Treatment Market Size by Application (2015-2020)
5.2 Global Behcet Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Behcet Disease Treatment Market Size (2015-2020)
6.2 Behcet Disease Treatment Key Players in North America (2019-2020)
6.3 North America Behcet Disease Treatment Market Size by Type (2015-2020)
6.4 North America Behcet Disease Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Behcet Disease Treatment Market Size (2015-2020)
7.2 Behcet Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Behcet Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Behcet Disease Treatment Market Size by Application (2015-2020)

8 China
8.1 China Behcet Disease Treatment Market Size (2015-2020)
8.2 Behcet Disease Treatment Key Players in China (2019-2020)
8.3 China Behcet Disease Treatment Market Size by Type (2015-2020)
8.4 China Behcet Disease Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Behcet Disease Treatment Market Size (2015-2020)
9.2 Behcet Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Behcet Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Behcet Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Behcet Disease Treatment Market Size (2015-2020)
10.2 Behcet Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Behcet Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Behcet Disease Treatment Market Size by Application (2015-2020)

11 India
11.1 India Behcet Disease Treatment Market Size (2015-2020)
11.2 Behcet Disease Treatment Key Players in India (2019-2020)
11.3 India Behcet Disease Treatment Market Size by Type (2015-2020)
11.4 India Behcet Disease Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Behcet Disease Treatment Market Size (2015-2020)
12.2 Behcet Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Behcet Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Behcet Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AbbVie Inc
13.1.1 AbbVie Inc Company Details
13.1.2 AbbVie Inc Business Overview
13.1.3 AbbVie Inc Behcet Disease Treatment Introduction
13.1.4 AbbVie Inc Revenue in Behcet Disease Treatment Business (2015-2020))
13.1.5 AbbVie Inc Recent Development
13.2 Celgene Corp
13.2.1 Celgene Corp Company Details
13.2.2 Celgene Corp Business Overview
13.2.3 Celgene Corp Behcet Disease Treatment Introduction
13.2.4 Celgene Corp Revenue in Behcet Disease Treatment Business (2015-2020)
13.2.5 Celgene Corp Recent Development
13.3 Coherus BioSciences Inc
13.3.1 Coherus BioSciences Inc Company Details
13.3.2 Coherus BioSciences Inc Business Overview
13.3.3 Coherus BioSciences Inc Behcet Disease Treatment Introduction
13.3.4 Coherus BioSciences Inc Revenue in Behcet Disease Treatment Business (2015-2020)
13.3.5 Coherus BioSciences Inc Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview
13.4.3 Novartis AG Behcet Disease Treatment Introduction
13.4.4 Novartis AG Revenue in Behcet Disease Treatment Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 R Pharm
13.5.1 R Pharm Company Details
13.5.2 R Pharm Business Overview
13.5.3 R Pharm Behcet Disease Treatment Introduction
13.5.4 R Pharm Revenue in Behcet Disease Treatment Business (2015-2020)
13.5.5 R Pharm Recent Development
13.6 Cell Medica Ltd
13.6.1 Cell Medica Ltd Company Details
13.6.2 Cell Medica Ltd Business Overview
13.6.3 Cell Medica Ltd Behcet Disease Treatment Introduction
13.6.4 Cell Medica Ltd Revenue in Behcet Disease Treatment Business (2015-2020)
13.6.5 Cell Medica Ltd Recent Development
13.7 Panacea Biotec Ltd
13.7.1 Panacea Biotec Ltd Company Details
13.7.2 Panacea Biotec Ltd Business Overview
13.7.3 Panacea Biotec Ltd Behcet Disease Treatment Introduction
13.7.4 Panacea Biotec Ltd Revenue in Behcet Disease Treatment Business (2015-2020)
13.7.5 Panacea Biotec Ltd Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Behcet Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Behcet Disease Treatment Revenue
Table 3. Ranking of Global Top Behcet Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Behcet Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Adalimumab Biosimilar
Table 6. Key Players of Apremilast
Table 7. Key Players of Canakinumab
Table 8. Key Players of Infliximab Biosimilar
Table 9. Key Players of Others
Table 10. Global Behcet Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Behcet Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Behcet Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Behcet Disease Treatment Market Share by Regions (2015-2020)
Table 14. Global Behcet Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Behcet Disease Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Behcet Disease Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Behcet Disease Treatment Players
Table 21. Global Behcet Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Behcet Disease Treatment Market Share by Players (2015-2020)
Table 23. Global Top Behcet Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Behcet Disease Treatment as of 2019)
Table 24. Global Behcet Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Behcet Disease Treatment Product Solution and Service
Table 27. Date of Enter into Behcet Disease Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Behcet Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Behcet Disease Treatment Market Size Share by Type (2015-2020)
Table 31. Global Behcet Disease Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Behcet Disease Treatment Market Size Share by Application (2015-2020)
Table 33. Global Behcet Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Behcet Disease Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Behcet Disease Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Behcet Disease Treatment Market Share (2019-2020)
Table 37. North America Behcet Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Behcet Disease Treatment Market Share by Type (2015-2020)
Table 39. North America Behcet Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Behcet Disease Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Behcet Disease Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Behcet Disease Treatment Market Share (2019-2020)
Table 43. Europe Behcet Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Behcet Disease Treatment Market Share by Type (2015-2020)
Table 45. Europe Behcet Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Behcet Disease Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Behcet Disease Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Behcet Disease Treatment Market Share (2019-2020)
Table 49. China Behcet Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Behcet Disease Treatment Market Share by Type (2015-2020)
Table 51. China Behcet Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Behcet Disease Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Behcet Disease Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Behcet Disease Treatment Market Share (2019-2020)
Table 55. Japan Behcet Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Behcet Disease Treatment Market Share by Type (2015-2020)
Table 57. Japan Behcet Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Behcet Disease Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Behcet Disease Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Behcet Disease Treatment Market Share (2019-2020)
Table 61. Southeast Asia Behcet Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Behcet Disease Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Behcet Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Behcet Disease Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Behcet Disease Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Behcet Disease Treatment Market Share (2019-2020)
Table 67. India Behcet Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Behcet Disease Treatment Market Share by Type (2015-2020)
Table 69. India Behcet Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Behcet Disease Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Behcet Disease Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Behcet Disease Treatment Market Share (2019-2020)
Table 73. Central & South America Behcet Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Behcet Disease Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Behcet Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Behcet Disease Treatment Market Share by Application (2015-2020)
Table 77. AbbVie Inc Company Details
Table 78. AbbVie Inc Business Overview
Table 79. AbbVie Inc Product
Table 80. AbbVie Inc Revenue in Behcet Disease Treatment Business (2015-2020) (Million US$)
Table 81. AbbVie Inc Recent Development
Table 82. Celgene Corp Company Details
Table 83. Celgene Corp Business Overview
Table 84. Celgene Corp Product
Table 85. Celgene Corp Revenue in Behcet Disease Treatment Business (2015-2020) (Million US$)
Table 86. Celgene Corp Recent Development
Table 87. Coherus BioSciences Inc Company Details
Table 88. Coherus BioSciences Inc Business Overview
Table 89. Coherus BioSciences Inc Product
Table 90. Coherus BioSciences Inc Revenue in Behcet Disease Treatment Business (2015-2020) (Million US$)
Table 91. Coherus BioSciences Inc Recent Development
Table 92. Novartis AG Company Details
Table 93. Novartis AG Business Overview
Table 94. Novartis AG Product
Table 95. Novartis AG Revenue in Behcet Disease Treatment Business (2015-2020) (Million US$)
Table 96. Novartis AG Recent Development
Table 97. R Pharm Company Details
Table 98. R Pharm Business Overview
Table 99. R Pharm Product
Table 100. R Pharm Revenue in Behcet Disease Treatment Business (2015-2020) (Million US$)
Table 101. R Pharm Recent Development
Table 102. Cell Medica Ltd Company Details
Table 103. Cell Medica Ltd Business Overview
Table 104. Cell Medica Ltd Product
Table 105. Cell Medica Ltd Revenue in Behcet Disease Treatment Business (2015-2020) (Million US$)
Table 106. Cell Medica Ltd Recent Development
Table 107. Panacea Biotec Ltd Company Details
Table 108. Panacea Biotec Ltd Business Overview
Table 109. Panacea Biotec Ltd Product
Table 110. Panacea Biotec Ltd Revenue in Behcet Disease Treatment Business (2015-2020) (Million US$)
Table 111. Panacea Biotec Ltd Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Behcet Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Adalimumab Biosimilar Features
Figure 3. Apremilast Features
Figure 4. Canakinumab Features
Figure 5. Infliximab Biosimilar Features
Figure 6. Others Features
Figure 7. Global Behcet Disease Treatment Market Share by Application: 2020 VS 2026
Figure 8. Home Care Case Studies
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Behcet Disease Treatment Report Years Considered
Figure 12. Global Behcet Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Behcet Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Behcet Disease Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Behcet Disease Treatment Market Share by Players in 2019
Figure 17. Global Top Behcet Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Behcet Disease Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Behcet Disease Treatment Revenue in 2019
Figure 19. North America Behcet Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Behcet Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Behcet Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Behcet Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Behcet Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Behcet Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Behcet Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介

ベーチェット病治療薬の世界市場（～2026年）

Global Behcet Disease Drug Market Insights and Forecast to 2026
MRC2-11QY03043 2020年11月20日 112Pages
当調査資料はベーチェット病治療薬のグローバル市場について調査・分析したレポートです。種類別（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他）市場規模、用途別（在宅介護、病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

クッシング病治療の世界市場（～2026年）

Global Cushing’s Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11540 2020年11月25日 99Pages
当調査資料はクッシング病治療のグローバル市場について調査・分析したレポートです。種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、クリニック、Eコマース/オンライン薬局）市場規模、地域...

ニューカッスル病治療の世界市場（～2026年）

Global Newcastle Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03968 2020年11月20日 99Pages
当調査資料はニューカッスル病治療のグローバル市場について調査・分析したレポートです。種類別（弱毒生ワクチン、不活化ワクチン、複合ワクチン）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

感染症治療の世界市場（～2026年）

Global Infectious Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12367 2020年11月25日 91Pages
当調査資料は感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗菌、抗真菌薬、抗ウイルス薬）市場規模、用途別（病院・クリニック、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

レイノー病治療の世界市場（～2026年）

Global Raynauds Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04462 2020年11月20日 91Pages
当調査資料はレイノー病治療のグローバル市場について調査・分析したレポートです。種類別（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

人獣共通感染症治療の世界市場（～2026年）

Global Zoonotic Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY05134 2020年11月20日 93Pages
当調査資料は人獣共通感染症治療のグローバル市場について調査・分析したレポートです。種類別（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

ポンペ病治療の世界市場（～2026年）

Global Pompe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04326 2020年11月20日 95Pages
当調査資料はポンペ病治療のグローバル市場について調査・分析したレポートです。種類別（乳児期発症ポンペ病、成人発症ポンペ病）市場規模、用途別（病院、医療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

メニエール病治療の世界市場（～2026年）

Global Meniere's Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12649 2020年11月25日 98Pages
当調査資料はメニエール病治療のグローバル市場について調査・分析したレポートです。種類別（投薬、非侵襲的治療・手順、中耳注射、手術、その他）市場規模、用途別（病院、クリニック、医学研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

キャッスルマン病治療の世界市場（～2026年）

Global Castleman Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11288 2020年11月25日 93Pages
当調査資料はキャッスルマン病治療のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、化学療法、放射線療法、免疫療法、コルチコステロイド、抗ウイルス薬）市場規模、用途別（病院、臨床、外来診療ユニット）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

ベーチェット病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Behcet Disease Drug Market The global Behcet Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Behcet Disease Drug Scope and Market Size Behcet Disease Drug market is seg…
クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
レイノー病治療の世界市場（～2026年） Market Analysis and Insights: Global Raynauds Disease Treatment Market The global Raynauds Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Raynauds Disease Treatment Scope and Market Size Raynauds Dis…
クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…